Showing results (141-150 of 171) with videos related to
Sort By:
Pageof 18
Journal of Neuroinflammation|April 17, 2024
IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onsetKevin Budding, Jeroen W Bos, Kim Dijkxhoorn, et al.Neurology. Genetics|February 12, 2020
Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophyRenske I Wadman, Marc D Jansen, Chantall A D Curial, et al.Neurobiology of Aging|November 15, 2011
VCP mutations in familial and sporadic amyotrophic lateral sclerosisMax Koppers, Marka M van Blitterswijk, Lotte Vlam, et al.The Lancet. Neurology|February 6, 2010
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trialIvo N van Schaik, Filip Eftimov, Pieter A van Doorn, et al.Orphanet Journal of Rare Diseases|April 12, 2020
Natural history of lung function in spinal muscular atrophyCamiel A Wijngaarde, Esther S Veldhoen, Ruben P A van Eijk, et al.Orphanet Journal of Rare Diseases|February 22, 2022
Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort studyEsther S Veldhoen, Camiel A Wijngaarde, Erik H J Hulzebos, et al.Iscience|May 19, 2025
Comprehensive analysis across SMN2 excludes DNA methylation as an epigenetic biomarker for spinal muscular atrophyMaria M Zwartkruis, Joris V Kortooms, Demi Gommers, et al.Orphanet Journal of Rare Diseases|February 24, 2023
Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort studyEsther S Veldhoen, Camiel A Wijngaarde, Ruben P A van Eijk, et al.Brain Communications|January 12, 2023
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4Marloes Stam, Camiel A Wijngaarde, Bart Bartels, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 11, 2021
Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor NeuropathyKevin Budding, Lill Eva Johansen, Inge Van de Walle, et al.Pageof 18